Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital

doi:10.1016/j.jhin.2007.06.017

Journal of Hospital Infection

Volume 67, Issue 1, September 2007, Pages 22-29

https://doi.org/10.1016/j.jhin.2007.06.017 Get rights and content

Summary

Despite enormous clinical experience of using peripheral vascular catheters, there is still controversy over the incidence and clinical relevance of bloodstream infections caused by these devices and the measures for preventing them. We performed a prospective study to determine the clinical epidemiology and outcomes of nosocomial bloodstream infections caused by short- and mid-line peripheral venous catheters among a group of non-intensive care unit patients. Cases of peripheral venous catheter-related bloodstream infections (PVC-BSIs) were compared to cases of central venous catheter-related bloodstream infections (CVC-BSIs). From October 2001 to March 2003, 150 cases of vascular catheter-related bloodstream infections were identified among 147 patients. Seventy-seven episodes (0.19 cases/1000 patient-days) were PVC-BSIs and 73 episodes (0.18 cases/1000 patient-days) were CVC-BSIs. Compared with CVC-BSIs, patients with PVC-BSIs more often had the catheter inserted in the emergency department (0 vs 42%), had a shorter duration from catheter insertion to bacteraemia (mean: 15.4 vs 4.9 days) and had Staphylococcus aureus (33 vs 53%) more frequently as the causative pathogen. Among patients with PVC-BSIs, catheters inserted in the emergency department had a significantly shorter duration in situ compared with those inserted on hospital wards (mean: 3.7 vs 5.7 days). Patients with PVC-BSIs caused by S. aureus had a higher rate of complicated bacteraemia (7%) and higher overall mortality (27%) than patients with PVC-BSIs caused by other pathogens (0 and 11%, respectively). Bloodstream infections remain underestimated and potentially serious complications of peripheral vascular catheterisation. Targeted interventions should be introduced to minimise this complication.

Introduction

Although largely preventable, vascular catheter-related bloodstream infections (VCR-BSIs) are frequent and potentially serious infections among hospitalised patients.¹ Bacteraemia due to vascular catheters prolongs hospital stay and increases both healthcare costs and morbidity and mortality rates, particularly when caused by invasive pathogens such as Staphylococcus aureus.2, 3

It is widely accepted that among hospitalised patients, central venous catheters (CVCs) pose a greater risk for VCR-BSIs than do peripheral vascular catheters (PVCs).4, 5 However, the enormous number of PVCs currently used in clinical practice may result in an increasing number of PVC-related complications such as phlebitis, thrombosis and bacteraemia.6, 7

Despite the recent publication by the Centers for Disease Control and Prevention (CDC) of a new set of guidelines for intravenous catheter maintenance and insertion, as well as extensive clinical experience, intense controversy remains concerning the relevance of and preventive measures for PVC-BSIs.8, 9, 10, 11 The objective of our study was to describe the clinical epidemiology and outcomes of PVC-BSIs among non-intensive care unit (ICU) patients identified in our hospital during an 18 month period, comparing the most relevant features to those cases caused by CVCs during the same period.

Section snippets

Setting and study population

The Hospital Universitari de Bellvitge is a 900-bed university-affiliated hospital for adult patients in the Barcelona area. Our hospital is a reference institution that provides healthcare for an area inhabited by more than one million people. The yearly admittance rate in 2002 was 28000 patients. Of these, 13000 were hospitalised directly from the emergency department.

The study population included all hospitalised patients on medical and surgical wards, excluding intensive care units, from

Results

According to our prevalence surveys, the use of intravascular catheters among hospitalised patients significantly increased from 20% in 1992 to 51% in 2002, and consequently the use of PVCs from 11 to 33% of inpatients (Figure 1). During the same period there was a decrease in the mean length of hospital stay from 16.3 to 12.2 days (P < 0.01), and a significant increase in mean age of inpatients from 55.8 to 61.2 (P = 0.01).

From October 2001 to March 2003, 150 cases of VCR-BSIs were identified

Discussion

The results of the targeted surveillance programme performed in our hospital, among non-ICU patients, showed that the number of BSIs caused by PVC infection was at least as frequent as CVC-BSIs. These results reinforce the concept that peripheral catheters can be one of the most frequent causes of nosocomial bacteraemia in some hospitals and suggest the need to introduce prospective surveillance programmes to detect this problem. A device-specific infection rate, similar to those defined for

Conflict of interest statement

None.

Funding sources

Supported by Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Spanish Network for Research in Infectious Diseases (REIPI C03/14 and REIPI RD06/0008).

References (24)

S. Harbarth et al.
The preventable proportion of nosocomial infections: an overview of published reports
J Hosp Infect
(2003)
V. Tagalakis et al.
The epidemiology of peripheral vein infusion thrombophlebitis: a critical review
Am J Med
(2002)
F. Vandenbos et al.
Relevance and complications of intravenous infusion at the emergency unit at Nice university hospital
J Infect
(2003)
D.G. Maki et al.
The risk of bloodstream infections in adults with different intravascular devices: a systematic review of 200 published prospective studies
Mayo Clin Proc
(2006)
R. Coello et al.
Device-related sources of bacteraemia in English hospitals: opportunities for the prevention of hospital-acquired bacteraemia
J Hosp Infect
(2003)
C. Chapoutot et al.
Staphylococcus aureus nasal carriage in 104 cirrhotic and control patients. A prospective study
J Hepatol
(1999)
V.H. Chu et al.
Staphylococcus aureus bacteremia in patients with prosthetic devices: cost and outcomes
Am J Med
(2005)
A.G. Jensen
Importance of focus identification in the treatment of Staphylococcus aureus bacteraemia
J Hosp Infect
(2002)
J.B. Dimick et al.
Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit
Arch Surg
(2001)
R.P. Wenzel et al.
The impact of hospital-acquired bloodstream infections
Emerg Infect Dis
(2001)

Centers for Disease Control and Prevention

National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 to June 2002, issued August 2002

Am J Infect Control

(2002)

R.P. Vomberg et al.

Device-associated infection rates for non-intensive care unit patients

Infect Control Hosp Epidemiol

(2006)

Cited by (125)

Peripheral intravenous catheter infection and failure: A systematic review and meta-analysis
2024, International Journal of Nursing Studies
Peripheral intravenous catheters are the most frequently used invasive device in nursing practice, yet are commonly associated with complications. We performed a systematic review to determine the prevalence of peripheral intravenous catheter infection and all-cause failure.
The Cochrane Library, PubMed, CINAHL, and EMBASE were searched for observational studies and randomised controlled trials that reported peripheral intravenous catheter related infections or failure. The review was limited to English language and articles published from the year 2000. Pooled estimates were calculated with random-effects models. Meta-analysis of observation studies in epidemiology guidelines and the Cochrane process for randomised controlled trials were used to guide the review. Prospero registration number: CRD42022349956.
Our search retrieved 34,725 studies. Of these, 41 observational studies and 28 randomised controlled trials (478,586 peripheral intravenous catheters) met inclusion criteria. The pooled proportion of catheter-associated bloodstream infections was 0.028 % (95 % confidence interval (CI): 0.009–0.081; 38 studies), or 4.40 catheter-associated bloodstream infections per 100,000 catheter-days (20 studies, 95 % CI: 3.47–5.58). Local infection was reported in 0.150 % of peripheral intravenous catheters (95 % CI: 0.047–0.479, 30 studies) with an incidence rate of 65.1 per 100,000 catheter-days (16 studies; 95 % CI: 49.2–86.2). All cause peripheral intravenous catheter failure before treatment completion occurred in 36.4 % of catheters (95 % CI: 31.7–41.3, 53 studies) with an overall incidence rate of 4.42 per 100 catheter days (78,891 catheter days; 19 studies; 95 % CI: 4.27–4.57).
Peripheral intravenous catheter failure is a significant worldwide problem, affecting one in three catheters. Per peripheral intravenous catheter, infection occurrence was low, however, with over two billion catheters used globally each year, the absolute number of infections and associated burden remains high. Substantial and systemwide efforts are needed to address peripheral intravenous catheter infection and failure and the sequelae of treatment disruption, increased health costs and poor patient outcomes.
Clinical outcomes and epidemiological characteristics of bacteremia in the older Japanese population
2023, Journal of Infection and Chemotherapy
The characteristics and clinical consequences of bacteremia in older people, who are highly susceptible to infections, need to be clarified. This study aimed to determine the epidemiological characteristics, prognosis, and predictors of 7-day mortality in patients with community-acquired (CA), healthcare-associated (HCA), and hospital-onset (HO) bacteremia in older adults aged ≥65 years.
Patients aged ≥65 years with positive blood cultures between April 1, 2015, and March 31, 2018, were divided into three groups: pre-old (65–74 years), old (75–89 years), and super-old (≥90 years). Characteristics based on medical exposure, including CA, HCA, and HO, were also compared and factors related to mortality were identified.
Overall, 1716 episodes of bacteremia were identified in 1415 patients. Of the 1211 episodes without contamination, 32.8%, 54.3%, and 12.9% occurred in pre-old, old, and super-old patients. Central line-associated bloodstream infections were more common in pre-old patients and urinary tract infections in the old and super-old. The 7-day mortality rates in the pre-old, old, and super-old groups were 7.4%, 5.8%, and 14.2% (P = 0.002), respectively. Multivariable logistic regression showed that super-old age (adjusted odds ratio, aOR: 2.09 [1.13–3.88], P = 0.019) and HO bacteremia (aOR: 1.97 [1.18–3.28], P = 0.010) were independent risk factors for 7-day mortality. Infectious disease consultation had a protective effect on 7-day mortality (aOR: 0.59 [0.35–0.99], P = 0.047).
The epidemiology of bacteremia differs among older people; thus, they should not be treated as a single entity. A careful approach is needed for the optimal management of bacteremia in these vulnerable patients.
Best practice in the use of peripheral venous catheters: A scoping review and expert consensus
2023, Infection Prevention in Practice
Peripheral intravenous catheters (PIVCs) are the most commonly used invasive medical device in health care with an overall failure rate of 35–50%. Most complications are non-infectious, but local site and bloodstream infections can also occur. Even if PIVC-related infections are rare, the total number of affected patients and the preponderance of Staphylococcus aureus as related pathogen due to the frequent use of these devices are relevant arguments to implement preventive strategies. The aim of this document is to raise awareness that infections caused by PIVCs are a relevant problem that can be reduced by practice change.
A panel of experts discussed this topic based on evidence and proposed practice points by consensus.
Despite published evidence-based guidelines, current practice concerning aseptic techniques during insertion and care of PIVCs often are substandard. These devices have become commonplace and tend to be perceived as safe. An overall lack of awareness about the true risks associated with the use of PIVCs results in limited surveillance and prevention efforts.
Successful insertion and maintenance bundles in central venous lines are a blueprint to the implementation of adapted bundle strategies in the prevention of PIVC-associated infections. There is a need for studies to specifically investigate infection prevention in PIVCs and to agree on effective and implementable bundles.
Microbiological colonization of peripheral venous catheters: a prospective observational study in a Swedish county hospital
2021, Infection Prevention in Practice
Citation Excerpt :
Some of the most problematic complications due to PVCs are phlebitis, thrombosis and infection [2]. PVC-related (PVCR) infections cause morbidity, mortality and increased healthcare costs [3,4]. In clinical practice, a PVCR bloodstream infection (BSI) may be overlooked when thrombophlebitis or cultures from PVCs are absent.
Most peripheral venous catheters (PVCs) used in Scandinavia are fitted with an injection port, creating an open PVC system. This port is difficult to disinfect, which may lead to the introduction of micro-organisms upon use.
To investigate the prevalence of microbiological colonization of the injection port and internal lumen of ported PVCs with a minimum dwell time of 48 h at sample collection.
Adult patients admitted to different medical and surgical departments and the intensive care unit were invited to participate in this prospective observational study. With the PVC in situ, the injection port and internal lumen were swabbed and cultured separately. Demographic and clinical data were collected to compare patients with colonized and non-colonized PVCs.
In total, 300 PVCs from 300 patients were analysed. Of these, 33 patients (11.0%) had at least one positive culture. The colonization locations were as follows: port only, 26 (8.7%); internal lumen only, 5 (1.7%); and port and internal lumen, 2 (0.7%). The colonization rate was significantly higher in the injection port than in the internal lumen (P<0.0001). A ported PVC inserted in the hand incurred a significant risk of colonization (P=0.03). The odds ratio for colonization among patients in the infectious diseases department was 0.1 (95% confidence interval 0.1–1; P<0.06) compared with patients in the medical department.
This study showed that 11% of ported PVCs were colonized by micro-organisms, with the vast majority (8.7%) of colonization occurring in the injection port.
ClinicalTrials.gov; ID NCT03351725.
‘How many audits do you really need?’: Learnings from 5-years of peripheral intravenous catheter audits
2021, Infection, Disease and Health
Peripheral intravenous catheters (PIVCs) are medical devices used to administer intravenous therapy but can be complicated by soft tissue or bloodstream infection. Monitoring PIVC safety and quality through clinical auditing supports quality infection prevention however is labour intensive. We sought to determine the optimal patient ‘number’ for clinical audits to inform evidence-based surveillance.
We studied a dataset of cross-sectional PIVC clinical audits collected over five years (2015–2019) in a large Australian metropolitan hospital. Audits included adult medical, surgical, women's, cancer, emergency and critical care patients, with audit sizes of 69–220 PIVCs. The primary outcome was PIVC complications for one or more patient reported symptom/auditor observed sign of infection or other complications. Complication prevalence and 95% confidence interval (CI) were calculated. We modelled scenarios of low (10%), medium (20%) and high (50%) prevalence estimates against audit sizes of 20, 50, 100, 150, 200, 250, and 300. This was used to develop a decision-making tool to guide audit size.
Of 2274 PIVCs evaluated, 475 (21%) had a complication. Complication prevalence per round varied from 7.8% (95% CI, 4.2–12.9) to 39% (95% CI, 32.0–46.4). Precision improved with larger audit size and lower complication rates. However, precision was not meaningfully improved by auditing >150 patients at a complication rate of 20% (95% CI 13.9%–27.3%), nor >200 patients at a complication rate of 50% (95% CI 42.9%–57.1%).
Audit sizes should be 100 to 250 PIVCs per audit round depending on complication prevalence.
Tissue adhesives for peripheral intravenous catheter securement: A prospective randomized controlled pilot trial
2021, American Journal of Emergency Medicine
In some patients securing the peripheral intravenous cannula (PIVC) with a standard adhesive dressing can be difficult because of sweat or other body fluids. The aim of our study was to evaluate the use of tissue adhesives alone as a means to secure PIVCs inserted in the emergency department.
We performed a prospective interventional pilot study from November 2019 to May 2020 in a medical emergency department of an urban tertiary hospital. Patients were randomized to two groups: tissue adhesives (TA) or adhesive dressing (AD) group. After randomization we followed them until day 4.
There were no significant differences between TA and AD groups in the rate of unplanned removal of PIVCs in the first 72 h (57.1% vs. 45.8%, p = 0.29), the rate of unplanned removal of PIVCs in the ED (0% vs. 2.1%, p = 1.00), the rate of unplanned removal of PIVC in the first 24 h (42.8% vs. 35.4%, p = 0.52), as well as in the rate of phlebitis (7.1% vs. 14.6%, p = 0.34) and the rate of any blood-stream infection (0% vs. 0%, p = 1.00).
We did not observe any significant differences when PIVCs inserted in the emergency department were secured with tissue adhesives alone, compared to standard adhesive dressings. We observed a high rate of unplanned removal of PIVCs, necessitating further research to determine more reliable ways of securing PIVCs.

View all citing articles on Scopus

View full text

Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital

Summary

Introduction

Section snippets

Setting and study population

Results

Discussion

Conflict of interest statement

Funding sources

J Hosp Infect

Am J Med

J Infect

Mayo Clin Proc

J Hosp Infect

J Hepatol

Am J Med

J Hosp Infect

Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit

Arch Surg

The impact of hospital-acquired bloodstream infections

Emerg Infect Dis

National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 to June 2002, issued August 2002

Am J Infect Control

Device-associated infection rates for non-intensive care unit patients

Infect Control Hosp Epidemiol